NCT05906914View on ClinicalTrials.gov

Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Myeloid Leukemia, Adult
Interventions
DRUG

cladribine + homoharringtonine + cytarabine

CHA Protocol: cladribine (5mg/m2, d1-3) + homoharringtonine (2mg/m2, d1-5) + cytarabine (100mg/m2 d1-7).

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER